Work

Supplementary Figure from Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure from Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361940492
Cites:
Cited by:
Related to: 10